Benzinga Rankings give you vital metrics on any stock – anytime.
Explore Windtree Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for WINT.
You can purchase shares of Windtree Therapeutics (NASDAQ:WINT) through any online brokerage.
Other companies in Windtree Therapeutics’s space includes: ZyVersa Therapeutics (NASDAQ:ZVSA), Vincerx Pharma (NASDAQ:VINC), Bone Biologics (NASDAQ:BBLG), Qualigen Therapeutics (NASDAQ:QLGN) and Shuttle Pharmaceuticals (NASDAQ:SHPH).
Windtree Therapeutics has a consensus price target of $7.00.
The stock price for Windtree Therapeutics (NASDAQ: WINT) is $1.69 last updated March 25, 2025 at 7:34 AM EDT.
There are no upcoming dividends for Windtree Therapeutics.
Windtree Therapeutics’s Q4 earnings are confirmed for Tuesday, April 15, 2025.
There is no upcoming split for Windtree Therapeutics.
Windtree Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.